Skip to main content
Premium Trial:

Request an Annual Quote

EU Therapeutics Program Hires Biobase to Help Develop Target ID Methods

NEW YORK (GenomeWeb News) — A group of European research institutes has hired Biobase to help it develop informatics tools and experimental methods for identifying therapeutic targets, the company said today.
 
Biobase said it will help develop bioinformatics and cheminformatics for the European Union-commissioned Net2Drug project, which is a consortium of institutes from Europe and Russia that represents interdisciplinary fields including toxicology, systems biology, pharmacology, and cancer.
 
The project “will integrate different omics datasets such as proteomics and genomics into cohesive networks” to help study diseases.
 
Any resulting methods or technologies will be tested on “certain tumor types,” particularly on breast cancer, said Alexander Kel, Biobase senior vice president of R&D.
 
Net2Drug is part of the EU’s Sixth Framework program, which was funded with $2.5 billion between 2002 and 2006, and which sets aside as much as $475 million for cancer research.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.